Literature DB >> 14971910

Anticancer and antimalarial efficacy and safety of artemisinin-derived trioxane dimers in rodents.

Gary H Posner1, Andrew J McRiner, Ik-Hyeon Paik, Surojit Sur, Kristina Borstnik, Suji Xie, Theresa A Shapiro, Adebusola Alagbala, Barbara Foster.   

Abstract

In only four chemical steps from naturally occurring artemisinin (1), trioxane dimers 6 and 7 were prepared on a multigram scale in overall 32-44% yields. In mice, both isonicotinate N-oxide dimer 6 and isobutyric acid dimer 7 were considerably more antimalarially efficacious than clinically used sodium artesunate (2) via both oral and intravenous administration. In the transgenic adenocarcinoma of mouse prostate model, some of the trioxane dimers had potent anticancer activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14971910     DOI: 10.1021/jm0303711

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  26 in total

1.  Synthesis, antiprotozoal, antimicrobial, β-hematin inhibition, cytotoxicity and methemoglobin (MetHb) formation activities of bis(8-aminoquinolines).

Authors:  Kirandeep Kaur; Meenakshi Jain; Shabana I Khan; Melissa R Jacob; Babu L Tekwani; Savita Singh; Prati Pal Singh; Rahul Jain
Journal:  Bioorg Med Chem       Date:  2010-11-25       Impact factor: 3.641

2.  Cytotoxic small molecule dimers and their inhibitory activity against human breast cancer cells.

Authors:  M Kyle Hadden; Brian S J Blagg
Journal:  Bioorg Med Chem Lett       Date:  2007-07-13       Impact factor: 2.823

Review 3.  Development of Anticancer Agents from Plant-Derived Sesquiterpene Lactones.

Authors:  Yulin Ren; Jianhua Yu; A Douglas Kinghorn
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

4.  pH-responsive artemisinin dimer in lipid nanoparticles are effective against human breast cancer in a xenograft model.

Authors:  Yitong J Zhang; Xi Zhan; Liguo Wang; Rodney J Y Ho; Tomikazu Sasaki
Journal:  J Pharm Sci       Date:  2015-03-09       Impact factor: 3.534

5.  Biological mechanisms of action of novel C-10 non-acetal trioxane dimers in prostate cancer cell lines.

Authors:  Adebusola A Alagbala; Andrew J McRiner; Kristina Borstnik; Tanzina Labonte; Wonsuk Chang; John G D'Angelo; Gary H Posner; Barbara A Foster
Journal:  J Med Chem       Date:  2006-12-28       Impact factor: 7.446

Review 6.  Development of artemisinin compounds for cancer treatment.

Authors:  Henry C Lai; Narendra P Singh; Tomikazu Sasaki
Journal:  Invest New Drugs       Date:  2012-08-31       Impact factor: 3.850

Review 7.  Recent advances in artemisinin production through heterologous expression.

Authors:  Patrick R Arsenault; Kristin K Wobbe; Pamela J Weathers
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

8.  Artemisinin-derived dimer phosphate esters as potent anti-cytomegalovirus (anti-CMV) and anti-cancer agents: a structure-activity study.

Authors:  Bryan T Mott; Ran He; Xiaochun Chen; Jennifer M Fox; Curt I Civin; Ravit Arav-Boger; Gary H Posner
Journal:  Bioorg Med Chem       Date:  2013-04-22       Impact factor: 3.641

9.  Identification of the anti-tumor activity and mechanisms of nuciferine through a network pharmacology approach.

Authors:  Quan Qi; Rui Li; Hui-Ying Li; Yu-Bing Cao; Ming Bai; Xiao-Jing Fan; Shu-Yan Wang; Bo Zhang; Shao Li
Journal:  Acta Pharmacol Sin       Date:  2016-05-16       Impact factor: 6.150

10.  Heme mediates cytotoxicity from artemisinin and serves as a general anti-proliferation target.

Authors:  Shiming Zhang; Glenn S Gerhard
Journal:  PLoS One       Date:  2009-10-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.